Mykhailo Mudryk Cleared to Return After Doping Ban

Mykhailo Mudryk’s long exile from competitive football is over.

The Chelsea winger has been cleared to return immediately after his four-year doping ban was resolved, closing a saga that has kept him out since November 2024 and left a major signing frozen on the sidelines.

A ban overturned by changing science

Mudryk, 25, was originally suspended after a drug test detected a low concentration of meldonium, a prohibited substance, from a sample taken two years ago. The punishment was severe: four years out of the game at what should have been the peak of his career.

He appealed to the Court of Arbitration for Sport (CAS). While that process rumbled on, the ground shifted beneath the case.

World Anti-Doping Agency (WADA) procedures changed. Under the updated scientific reporting standards, the kind of low-level meldonium concentration found in Mudryk’s sample would no longer trigger a charge at all.

The FA set out the key point starkly: if the same sample were collected today, it “would not have been reported and no anti-doping rule violations would have resulted”.

That development proved decisive.

With WADA’s agreement, the FA and Mudryk have now settled the appeal. As part of the resolution, he accepted that he had committed the Anti-Doping Rule Violations originally charged, but crucially, the period of ineligibility was capped at the time he has already served.

In other words, the punishment ends where the science now says the case would never have begun.

“Mr Mudryk is no longer ineligible and may return to competition with immediate effect,” the FA confirmed.

Chelsea’s £88m winger gets his restart

For Chelsea, it brings clarity over one of the most expensive and complicated chapters of their recent recruitment drive.

The Blues paid £88m to sign Mudryk from Shakhtar Donetsk in January 2023, a deal that was supposed to anchor their new era of big spending and long contracts. Instead, his progress stalled just as he was trying to settle into English football.

Now they finally have their winger back.

Chelsea welcomed the outcome in a club statement that underlined how far testing standards have moved since that original sample.

They highlighted the “acknowledgement that advances in the applicable scientific reporting standards for more reliable testing mean that, had Misha's sample been analysed under today's technical requirements, it would not have been reported as a positive test and no anti-doping rule violation would have resulted”.

For the club, that context matters. It frames Mudryk’s absence not as a simple disciplinary story, but as a case caught in the gap between old and new science.

The statement ended on a line that will echo around Cobham as pre-season plans take shape: the resolution “allows everyone involved to move forward.”

For Mudryk, that means one thing above all: boots back on, spotlight back on, career back in his own hands.